Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27942852 | 0.95 | TSHR (0.51) | TSHRMEN1KMT2APOLBHSD17B10 | |
| SCHEMBL17772767 | 0.93 | TSHR (0.50) | TSHRMEN1KMT2APOLBHSD17B10 | |
| SCHEMBL12287877 | 0.92 | TSHR (0.49) | TSHRMEN1KMT2APOLBHSD17B10 | |
| SCHEMBL13219660 | 0.91 | TSHR (0.50) | TSHRMEN1KMT2APOLBHSD17B10 | |
| SCHEMBL11252145 | 0.90 | KMT2A (0.53) | TSHRMEN1KMT2APOLBHSD17B10 | |
| SCHEMBL28543998 | 0.90 | KMT2A (0.53) | TSHRMEN1KMT2APOLBHSD17B10 | |
| SCHEMBL12928480 | 0.89 | TSHR (0.47) | TSHRMEN1KMT2APOLBHSD17B10 | |
| SCHEMBL12928444 | 0.89 | TSHR (0.47) | TSHRMEN1KMT2APOLBHSD17B10 | |
| SCHEMBL686318 | 0.88 | TSHR (0.50) | TSHRMEN1KMT2APOLBHSD17B10 | |
| SCHEMBL12263775 | 0.87 | TSHR (0.48) | TSHRMEN1KMT2APOLBHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260064002-A1 | PHOTOSENSITIVE COMPOSITION AND FILM PREPARED FROM THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2026-03-05 | — | — | US | claimed |
| US-20260064002-A1 | PHOTOSENSITIVE COMPOSITION AND FILM PREPARED FROM THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2026-03-05 | — | — | US | disclosed |
| WO-2025107100-A1 | EPOXY ADHESIVE INCLUDING POLYMERIC TOUGHENER AND CATIONIC PHOTOINITIATOR AND METHOD FOR USING SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-05-30 | — | — | WO | disclosed |
| WO-2025108217-A1 | EPOXY ADHESIVE INCLUDING POLYMERIC TOUGHENER, CATIONIC PHOTOINITIATOR, AND THERMAL CATIONIC INITIATOR AND METHOD FOR USING SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-05-30 | — | — | WO | disclosed |
| CN-119816483-A | (Meth) acryl-containing polycarboxylic acid compound, heat conductive composition, and heat conductive sheet | 迪睿合株式会社 | 2025-04-11 | — | — | CN | disclosed |
| CN-114286832-B | Photocurable resin composition for electronic device | 积水化学工业株式会社 | 2025-03-04 | — | — | CN | disclosed |
| US-20250051509-A1 | CURABLE RESIN COMPOSITION, VARNISH, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2025-02-13 | — | — | US | disclosed |
| WO-2025033020-A1 | THERMALLY CONDUCTIVE COMPOSITION, METHOD FOR PRODUCING LAMINATE, AND LAMINATE | デクセリアルズ株式会社 | 2025-02-13 | — | — | WO | disclosed |
| CN-113811558-B | Photocurable resin composition for electronic device | 积水化学工业株式会社 | 2025-01-28 | — | — | CN | disclosed |
| WO-2025016701-A1 | METHOD FOR CURING A CATIONICALLY POLYMERIZABLE EPOXY RESIN COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2025-01-23 | — | — | WO | disclosed |
| US-9575409-B2 | Photoimageable compositions containing oxetane functionality | PROMERUS, LLC (US) | 2017-02-21 | — | — | US | disclosed |
| US-20160147145-A1 | PHOTOIMAGEABLE COMPOSITIONS CONTAINING OXETANE FUNCTIONALITY | PROMERUS, LLC | 2016-05-26 | — | — | US | disclosed |
| WO-2014158015-A1 | RADIATION-CURABLE LIQUID RESIN COMPOSITION FOR OPTICAL THREE-DIMENSIONAL SHAPING, AND OPTICALLY SHAPED ARTICLE OBTAINED BY PHOTO-CURING THE SAME | DSM IP ASSETS B.V. (NL) | 2014-10-02 | — | — | WO | disclosed |
| WO-2014152543-A2 | OXETANE-CONTAINING COMPOUNDS AND COMPOSITIONS THEREOF | Henkel IP & Holding GmbH (DE) | 2014-09-25 | — | — | WO | disclosed |
| US-20140264165-A1 | OXETANE-CONTAINING COMPOUNDS AND COMPOSITIONS THEREOF | HENKEL CORPORATION (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140264165-A1 | OXETANE-CONTAINING COMPOUNDS AND COMPOSITIONS THEREOF | HENKEL CORPORATION (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140209951-A1 | OXETANE-CONTAINING COMPOUNDS AND COMPOSITIONS THEREOF | Henkel IP & Holding GmbH (DE) | 2014-07-31 | — | — | US | disclosed |
| US-20140209951-A1 | OXETANE-CONTAINING COMPOUNDS AND COMPOSITIONS THEREOF | Henkel IP & Holding GmbH (DE) | 2014-07-31 | — | — | US | disclosed |
| WO-2013049154-A2 | OXETANE-CONTAINING COMPOUNDS AND COMPOSITIONS THEREOF | HENKEL AG & CO. KGAA (DE) | 2013-04-04 | — | — | WO | disclosed |
| WO-2012014898-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学工業株式会社 (JP) | 2012-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260064002-A1 | PHOTOSENSITIVE COMPOSITION AND FILM PREPARED FROM THE SAME | OXER1, PTGER1, PTGER3 | TSHR 3662/4885MEN1 1600/4885KMT2A 1025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.